2022-2021

Publikationsliste 2022-2021

2022

262   F. E. Morreale, S. Kleine, J. Leodolter, S. Junker, D. M. Hoi, S. Ovchinnikov, A. Okun, J. Kley, R. Kurzbauer, L. Junk, S. Guha, D. Podlesainski, U. Kazmaier, G. Boehmelt, H. Weinstabl, K. Rumpel, V. M. Schmiedel, M. Hartl, D. Haselbach, A. Meinhart, M. Kaiser, T. Clausen, "BacPROTACs mediate targeted protein degradation in bacteria", Cell 2022, in press. DOI: 10.1016/j.cell.2022.05.009.

261   T. Kinsinger, U. Kazmaier, "Application of Vinyl Nucleophiles in Matteson Homologations", Org. Lett. 2022, 24, 3599−3603. DOI: 10.1021/acs.orglett.2c01119.

260   O. Andler, U. Kazmaier, "Stereoselective Synthesis of the Side Chain of Meliponamycin A", Org. Lett. 2022, 24, 2541−2545. DOI: 10.1021/acs.orglett.2c00701.

259   N. Neis, F. Xie, D. Krug, H. Zhao, A. Siebert, T. Binz, C. Fu, R. Müller, U. Kazmaier, "Stereoselective Syntheses of Deuterated Pipecolic Acids as Tools to Investigate the Stereoselectivity of the Hydroxylase GetF", Eur. J. Org. Chem. 2022, e202200162. DOI: 10.1002/ejoc.202200162.

258   V. Jakob, B. G. E. Zoller, J. Rinkes, Y. Wu, A. F. Kiefer, M. Hust, S. Helmsing, A. M. White, P. J. Harvey, T. Durek, D. J. Craik, A. Siebert, U. Kazmaier, M. Empting, "Phage Display-based Discovery of Cyclic Peptides against the Broad Spectrum Bacterial Anti-Virulence Target CsrA", Eur. J. Med. Chem. 2022, 231, 114148. DOI: 10.1016/j.ejmech.2022.114148.

257   P. Servatius, U. Kazmaier, "Synthesis and late stage modifications of Cyl-derivatives", Beilstein J. Org. Chem. 2022, 18, 174–181. DOI: 10.3762/bjoc.18.19.

2021

256   M. Tost, O. Andler, U. Kazmaier, "A Matteson homologation-based synthesis of doliculide and derivatives", Eur. J. Org. Chem. 2021, 6459–6471. DOI: 10.1002/ejoc.202101345.

255   O. Andler, U. Kazmaier, "Allylzinc Reagents: Versatile Nucleophiles in Matteson Homologations", Org. Lett. 2021, 23, 8439–8444. DOI: 10.1021/acs.orglett.1c03164.

254   S. Wang, M. Meixner, L. Yu, L. Karmann, U. Kazmaier, A. M. Vollmar, I. Antes, S. Zahler, "Turning the Actin Nucleating Compound Miuraenamide into Nucleation Inhibitors", ACS Omega 2021, 6, 22165–22172. DOI: 10.1021/acsomega.1c02838.

253   L. Franz, U. Kazmaier, A. W. Truman, J. Koehnke, "Bottromycins - Biosynthesis, Synthesis and Activity", Nat. Prod. Rep. 2021, 38, 1659–1683. DOI: 10.1039/d0np00097c.

252   U. Kazmaier, L. Junk, "The Synthesis of Ilamycins/Rufomycins and Cyclomarins, Marine Cyclopeptides that Demonstrate anti-Malaria and anti-Tuberculosis Activity", Mar. Drugs 2021, 19, 446. DOI: 10.3390/md19080446.

251   M. Kohr, U. Kazmaier, "C–H Functionalization of Peptides via Cyclic Aminal Intermediates", Org. Lett. 2021, 23, 5947-5951. DOI: 10.1021/acs.orglett.1c02041.

250   O. Andler, U. Kazmaier, "Total Synthesis of Apratoxin A and B using Matteson's Homologation Approach", Org. Biomol. Chem. 2021, 19, 4866–4870. DOI: 10.1039/d1ob00713k.

249   L. Junk, E. Papadopoulos, U. Kazmaier, "Tryptophan N1-Alkylation: Quick and Simple Access to Diversely Substituted Tryptophans", Synthesis 2021, 53, 2503–2511. DOI: 10.1055/a-1404-5079.

248   S. Kappler, U. Kazmaier, "Synthesis of modified miuraenamides – the Ugi approach", Arkivoc 2021, IV, 280–296. DOI: 10.24820/ark.5550190.p011.186.

247   S. Kappler, A. Siebert, U. Kazmaier, "Synthesis of New Cyclopeptide Analogues of the Miuraenamides", Curr. Org. Synth. 2021, 18, 418–424. DOI: 10.2174/1570179418666210113161550.

246   O. Andler, U. Kazmaier, "A Straightforward Synthesis of Polyketides via Ester Dienolate Matteson Homologation", Chem. Eur. J. 2021, 27, 949–953. DOI: 10.1002/chem.202004650.

245   U. Kazmaier, "The Long, Long Way to Bottromycin", Isr. J. Chem. 2021, 61, 302–321. DOI: 10.1002/ijch.202000068.